Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prashant Tembhare

Showing results (41-50 of 86) with videos related to

Pageof 9
Sort By:
International Journal of Hematology|September 3, 2020
Bortezomib and cyclophosphamide based chemo-mobilization in multiple myelomaBhausaheb Bagal, Anant Gokarn, Sachin Punatar, et al.
Indian Journal of Cancer|August 8, 2018
Clinicoepidemiological profiles, clinical practices, and the impact of holistic care interventions on outcomes of pediatric hematolymphoid malignancies - A 7-year audit of the pediatric hematolymphoid disease management group at Tata Memorial HospitalGaurav Narula, Maya Prasad, Shalini Jatia, et al.
Indian Journal of Pathology & Microbiology|February 15, 2017
Immunogenetics of chronic lymphocytic leukemiaNikhil Patkar, Nikhil Rabade, Pratibha Amare Kadam, et al.
Mediterranean Journal of Hematology and Infectious Diseases|January 13, 2018
Molecular Heterogeneity in Acute Promyelocytic Leukemia - a Single Center Experience from IndiaNikhil Rabade, Goutham Raval, Shruti Chaudhary, et al.
Cytometry. Part B, Clinical Cytometry|December 20, 2018
Assessment of plasma cell myeloma minimal residual disease testing by flow cytometry in an international inter-laboratory study: Is it ready for primetime use?Stuart D Scott, Matthew Fletcher, Helen Whitehouse, et al.
American Journal of Hematology|November 21, 2024
Treatment-Free Remissions in Children With Chronic Myeloid Leukemia (CML): A Prospective Study From the Tata Memorial Hospital (TMH) Pediatric CML (pCML) CohortNirmalya Roy Moulik, Swaminathan Keerthivasagam, Gaurav Chatterjee, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 1, 2021
Clinical course of severe COVID19 treated with tocilizumab and antivirals post-allogeneic stem cell transplant with extensive chronic GVHDSumeet Mirgh, Anant Gokarn, Sachin Punatar, et al.
Blood Cancer Journal|November 1, 2025
Treatment free remission (TFR) in chronic myeloid leukemia-results, compliance and patterns of failure from a tertiary care cancer centre in IndiaSachin Punatar, Nishant Jindal, Anant Gokarn, et al.
Molecular Cancer Research : MCR|January 31, 2020
The Th9 Axis Reduces the Oxidative Stress and Promotes the Survival of Malignant T Cells in Cutaneous T-Cell Lymphoma PatientsSushant Kumar, Bhavuk Dhamija, Soumitra Marathe, et al.
Indian Journal of Pathology & Microbiology|June 21, 2017
An integrated genomic profile that includes copy number alterations is highly predictive of minimal residual disease status in childhood precursor B-lineage acute lymphoblastic leukemiaNikhil Patkar, P G Subramanian, Prashant Tembhare, et al.
Pageof 9

Showing results (41-50 of 86) with videos related to

Sort By:
Pageof 9
International Journal of Hematology|September 3, 2020
Bortezomib and cyclophosphamide based chemo-mobilization in multiple myelomaBhausaheb Bagal, Anant Gokarn, Sachin Punatar, et al.
Indian Journal of Cancer|August 8, 2018
Clinicoepidemiological profiles, clinical practices, and the impact of holistic care interventions on outcomes of pediatric hematolymphoid malignancies - A 7-year audit of the pediatric hematolymphoid disease management group at Tata Memorial HospitalGaurav Narula, Maya Prasad, Shalini Jatia, et al.
Indian Journal of Pathology & Microbiology|February 15, 2017
Immunogenetics of chronic lymphocytic leukemiaNikhil Patkar, Nikhil Rabade, Pratibha Amare Kadam, et al.
Mediterranean Journal of Hematology and Infectious Diseases|January 13, 2018
Molecular Heterogeneity in Acute Promyelocytic Leukemia - a Single Center Experience from IndiaNikhil Rabade, Goutham Raval, Shruti Chaudhary, et al.
Cytometry. Part B, Clinical Cytometry|December 20, 2018
Assessment of plasma cell myeloma minimal residual disease testing by flow cytometry in an international inter-laboratory study: Is it ready for primetime use?Stuart D Scott, Matthew Fletcher, Helen Whitehouse, et al.
American Journal of Hematology|November 21, 2024
Treatment-Free Remissions in Children With Chronic Myeloid Leukemia (CML): A Prospective Study From the Tata Memorial Hospital (TMH) Pediatric CML (pCML) CohortNirmalya Roy Moulik, Swaminathan Keerthivasagam, Gaurav Chatterjee, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 1, 2021
Clinical course of severe COVID19 treated with tocilizumab and antivirals post-allogeneic stem cell transplant with extensive chronic GVHDSumeet Mirgh, Anant Gokarn, Sachin Punatar, et al.
Blood Cancer Journal|November 1, 2025
Treatment free remission (TFR) in chronic myeloid leukemia-results, compliance and patterns of failure from a tertiary care cancer centre in IndiaSachin Punatar, Nishant Jindal, Anant Gokarn, et al.
Molecular Cancer Research : MCR|January 31, 2020
The Th9 Axis Reduces the Oxidative Stress and Promotes the Survival of Malignant T Cells in Cutaneous T-Cell Lymphoma PatientsSushant Kumar, Bhavuk Dhamija, Soumitra Marathe, et al.
Indian Journal of Pathology & Microbiology|June 21, 2017
An integrated genomic profile that includes copy number alterations is highly predictive of minimal residual disease status in childhood precursor B-lineage acute lymphoblastic leukemiaNikhil Patkar, P G Subramanian, Prashant Tembhare, et al.
Pageof 9